Susceptibility testing and molecular classification of Paecilomyces spp.

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 8, 2008, Pages 2926-2928

  Castelli, Maria Victoria ^a   Alastruey Izquierdo, Ana ^a   Cuesta, Isabel ^a   Monzon, Araceli ^a   Mellado, Emilia ^a   Rodriguez Tudela, Juan L ^a   Cuenca Estrella, Manuel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ECHINOCANDIN B; ITRACONAZOLE; RAVUCONAZOLE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; FUNGAL GENE; FUNGAL STRAIN; FUNGUS ISOLATION; GENE SEQUENCE; GENETIC ANALYSIS; IN VITRO STUDY; MICROBIAL SENSITIVITY TEST; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PAECILOMYCES; PAECILOMYCES LILACINUS; PAECILOMYCES PARIOTII; PHYLOGENETIC TREE; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DNA, FUNGAL; DNA, RIBOSOMAL; ECHINOCANDINS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; PAECILOMYCES; PHYLOGENY;

EID: 48749104759     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00538-08     Document Type: Article

References (20)

1. Aberkane, A., M. Cuenca-Estrella, A. Gomez-Lopez, E. Petrikkou, E. Mellado, A. Monzon, J. L. Rodriguez-Tudela, and the Eurofung Network. 2002. Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. J. Antimicrob. Chemother. 50:719-722.
2. Antachopoulos, C., T. J. Walsh, and E. Roilides. 2007. Fungal infections in primary immunodeficiencies. Eur. J. Pediatr. 166:1099-1117.
3. Arikan, S., M. Lozano-Chiu, V. Paetznick, and J. H. Rex. 2001. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob. Agents Chemother. 45:327-330.
4. Carey, J., R. D'Amico, D. A. Sutton, and M. G. Rinaldi. 2003. Paecilomyces lilacinus vaginitis in an immunocompetent patient. Emerg. Infect. Dis. 9:1155-1158.
5. Castro, L. G., A. Salebian, and M. N. Sotto. 1990. Hyalohyphomycosis by Paecilomyces lilacinus in a renal transplant patient and a review of human Paecilomyces species infections. J. Med. Vet. Mycol. 28:15-26.
6. Chamilos, G., and D. P. Kontoyiannis. 2005. Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis. J. Infect. 51:e225-e228.
7. de Hoog, G., J. Guarro, C. S. Tan, R. G. F. Wintermans, and J. Gene. 1995. Hyphomycetes, p. 380-1007. In G. S. de Hoog and I. Guarro (ed.), Atlas of clinical fungi. Universitat Rovira i Virgili and Centraalbureau voor Schimmelcultures, Reus, España and Utrecht, The Netherlands.
8. Del Poeta, M., W. A. Schell, and J. R. Perfect. 1997. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrob. Agents Chemother. 41:1835-1836.
9. Gutierrez, F., M. Masia, J. Ramos, M. Elia, E. Mellado, and M. Cuenca-Estrella. 2005. Pulmonary mycetoma caused by an atypical isolate of Paecilomyces species in an immunocompetent individual: case report and literature review of Paecilomyces lung infections. Eur. J. Clin. Microbiol. Infect. Dis. 24:607-611.
10. Holden, D. W. 1994. DNA mini prep method for Aspergillus fumigatus (and other filamentous fungi), p. 3-4. In B. Maresca and G. S. Kobayashi (ed.), Molecular biology of pathogenic fungi, a laboratory manual. Telos Press, New York, NY.
11. Kurtz, M. B., I. B. Heath, J. Marrinan, S. Dreikorn, J. Onishi, and C. Douglas. 1994. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase. Antimicrob. Agents Chemother. 38:1480-1489.
12. Lass-Florl, C., M. Cuenca-Estrella, D. W. Denning, and J. L. Rodriguez-Tudela. 2006. Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology. Med. Mycol. 44(Suppl.):319-325.
13. Madsen, A. M., V. M. Hansen, N. V. Meyling, and J. Eilenberg. 2007. Human exposure to airborne fungi from genera used as biocontrol agents in plant production. Ann. Agric. Environ. Med. 14:5-24.
14. Clinical and Laboratory Standards Institute/NCCLS. 2005. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. Clinical and Laboratory Standards Institute, Wayne, PA.
15. Pastor, F. J., and J. Guarro. 2006. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin. Microbiol. Infect. 12:948-960.
16. Pastor, F. J., and J. Guarro. 2007. The role of voriconazole in the treatment of emerging mycoses. Rev. Iberoam. Micol. 24:228-232. (In Spanish.)
17. Petrikkou, E., J. L. Rodriguez-Tudela, M. Cuenca-Estrella, A. Gomez, A. Molleja, and E. Mellado. 2001. Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans. J. Clin. Microbiol. 39:1345-1347.
18. Rodriguez-Tudela, J. L., E. Chryssanthou, E. Petrikkou, J. Mosquera, D. W. Denning, and M. Cuenca-Estrella. 2003. Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi. J. Clin. Microbiol. 41:5236-5237.
19. Rodriguez-Tudela, J. L., T. M. Diaz-Guerra, E. Mellado, V. Cano, C. Tapia, A. Perkins, A. Gomez-Lopez, L. Rodero, and M. Cuenca-Estrella. 2005. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob. Agents Chemother. 49:4026-4034.
20. Uchida, K., Y. Nishiyama, N. Yokota, and H. Yamaguchi. 2000. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens. J. Antibiot. (Tokyo) 53:1175-1181.